Boulle N, Jones E M, Auguste P, Baird A
Department of Cell Biology, Scripps Research Institute, La Jolla, California 92037, USA.
Mol Endocrinol. 1995 Jun;9(6):767-75. doi: 10.1210/mend.9.6.8592522.
Basic fibroblast growth factor (FGF-2) is posttranslationally modified by the enzymatic transfer of ADP-ribose from nicotinamide adenine dinucleotide (NAD). When sonicated nuclei of adrenal capillary endothelial or SK-Hep1 cells are incubated with [32P]NAD, FGF-2 is rapidly ADP-ribosylated in a dose- and time-dependent fashion. Proteins structurally related to FGF-2 (FGF-6 and -7) are readily modified, suggesting that they share a common substrate motif. Yet, FGF-1, the most structurally homologous member of the FGF family, is a poor substrate. The reaction is also specific; interleukin-1 alpha, transforming growth factor-alpha, nerve growth factor, insulin-like growth factor-I, and granulocyte macrophage-colony stimulating factor are not substrates for ribosylation. Because the ADP ribosylation of FGF-2 is acid resistant but base and hydroxylamine sensitive, the linkage appears to be mediated through arginine. Most importantly, however, we also establish that endogenous FGF-2 is a substrate for ribosylation. As such, an immunoreactive ADP-ribosylated FGF-2 is detected in extracts of SK-Hep1 nuclei when they are incubated with [32P]NAD. Taken together, these findings suggest that the role played by ADP ribosylation in signal transduction, DNA repair, the control of the cell cycle, and cell differentiation may involve its ability to target molecules such as FGF-2.
碱性成纤维细胞生长因子(FGF-2)在翻译后通过烟酰胺腺嘌呤二核苷酸(NAD)的ADP-核糖基酶促转移进行修饰。当肾上腺毛细血管内皮细胞或SK-Hep1细胞的超声破碎核与[32P]NAD一起孵育时,FGF-2会以剂量和时间依赖性方式迅速进行ADP-核糖基化。与FGF-2结构相关的蛋白质(FGF-6和-7)很容易被修饰,这表明它们共享一个共同的底物基序。然而,FGF-1是FGF家族中结构同源性最高的成员,却是一种较差的底物。该反应也是特异性的;白细胞介素-1α、转化生长因子-α、神经生长因子、胰岛素样生长因子-I和粒细胞巨噬细胞集落刺激因子都不是核糖基化的底物。由于FGF-2的ADP核糖基化对酸具有抗性,但对碱和羟胺敏感,这种连接似乎是通过精氨酸介导的。然而,最重要的是,我们还确定内源性FGF-2是核糖基化的底物。因此,当SK-Hep1细胞核提取物与[32P]NAD一起孵育时,可检测到免疫反应性的ADP-核糖基化FGF-2。综上所述,这些发现表明ADP核糖基化在信号转导、DNA修复、细胞周期控制和细胞分化中所起的作用可能涉及其靶向FGF-2等分子的能力。